SCHEMBL7549855

SCHEMBL7549855

C=CC1CC(c2ccccc2)OC1c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.42
SLC6A2 P23975 2/20 0.36
SLC6A3 Q01959 2/20 0.36
SLC6A4 P31645 1/20 0.36
CHRM2 P08172 3/20 0.34
CHRM4 P08173 3/20 0.34
CHRM1 P11229 3/20 0.34
CHRM3 P20309 3/20 0.34
CHRM5 P08912 2/20 0.34
MAOB P27338 8/20 0.32
MAOA P21397 7/20 0.32
KDM1A O60341 5/20 0.32
CYP2C19 P33261 4/20 0.32
CYP2B6 P20813 3/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C9 P11712 2/20 0.32
HSD17B10 Q99714 2/20 0.32
TAAR1 Q96RJ0 2/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7547948 0.91 SLC6A3 (0.36) TSHRSLC6A2SLC6A3SLC6A4MAOB
SCHEMBL7552162 0.84 EPHX1 (0.41) CYP2C19CYP2D6CYP2C9LMNACYP3A4
SCHEMBL7550250 0.84 TSHR (0.41) TSHRSLC6A2SLC6A3SLC6A4MAOB
SCHEMBL7550412 0.73 CFTR (0.39) POLB
SCHEMBL7550942 0.71 SLC6A2 (0.45) TSHRSLC6A2SLC6A3SLC6A4CHRM2
SCHEMBL3189756 0.70 MAOB (0.48) SLC6A2SLC6A3MAOBMAOAKDM1A
SCHEMBL3189760 0.70 MAOB (0.48) SLC6A2SLC6A3MAOBMAOAKDM1A
SCHEMBL7555123 0.70 CFTR (0.44) CHRM2CHRM4CHRM1CHRM3CHRM5
SCHEMBL28117704 0.68 TSHR (0.36) TSHRSLC6A2SLC6A3SLC6A4MAOB
SCHEMBL28066085 0.68 TSHR (0.36) TSHRCHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002051883-A1 SYNTHESIS OF NOVEL HETEROCYCLIC MOLECULES OXYGENATED BY METATHESIS REACTION ON SOLID SUPPORT USING NOVEL SILYLATED LINKERS AVENTIS PHARMA S.A. (FR) 2002-07-04 WO disclosed